English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 心血管治療薬のラテンアメリカ市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

心血管治療薬のラテンアメリカ市場

Latin American Cardiovascular Drugs Markets

発行 Frost & Sullivan
出版日 2008年01月 商品コード 60407
ページ情報 英文  
価格
US$ 7,930 換算 ¥ 638,127 (税抜) Web Access (Regional License)
US$ 8,430 換算 ¥ 678,362 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service covers the Latin America Cardiovascular drugs market from 2004 to 2011, with 2006 as the base year. Major markets were studied: Brazil and the Andean Region (which includes Colombia and Venezuela, countries that are estimated to achieve double digit growth rates in the forecast period).

Table of Contents

1. MARKET OVERVIEW

Introduction

  • Executive Summary
  • Research Scope and Methodology
  • Market Segmentation
  • Glossary of Terms

Overview

  • Overview of the Latin American Cardiovascular Drugs Markets
  • Market Engineering Measurements
  • Regulatory Framework

2. CARDIOVASCULAR DRUGS MARKETS IN BRAZIL

Market Measurements

  • Market Profile and Measurements
  • Industry Challenges
  • Market Drivers
  • Market Restraints

Antihypertensive Drugs

  • Product Measurements
  • Product Pricing Analysis
  • Competitive Analysis

Antidyslipidemic Drugs

  • Product Measurements
  • Product Pricing Analysis
  • Competitive Analysis

Other Drugs (Antithrombotics and Antiarrhythmics)

  • Product Measurements
  • Product Pricing Analysis
  • Competitive Analysis

Product Distribution Analysis

  • Product Distribution Structure

Drug Pipelines

  • Cardiovascular Pipelines

3. CARDIOVASCULAR DRUGS MARKETS IN THE ANDEAN REGION (COLOMBIA AND VENEZUELA)

Market Measurements

  • Market Profile and Measurements
  • Industry Challenges
  • Market Drivers
  • Market Restraints

Antihypertensive Drugs

  • Product Measurements
  • Product Pricing Analysis
  • Competitive Analysis

Antidyslipidemic Drugs

  • Product Measurements
  • Product Pricing Analysis
  • Competitive Analysis

Other Drugs (Antithrombotics and Antiarrhythmics)

  • Product Measurements
  • Product Pricing Analysis
  • Competitive Analysis

Product Distribution Analysis

  • Product Distribution Structure

Drug Pipelines

  • Cardiovascular Pipelines

4. DECISION SUPPORT DATABASE

Decision Support Database

  • Total Healthcare Expenditure
  • Government Healthcare Expenditure
  • Private Healthcare Expenditure
  • Per Capita Healthcare Expenditure
  • Pharmaceutical R&D Expenditure
  • Prevalence of Hypertension
Back to Top